These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
6/26/2017
5:12 PM ET
Press Release

Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock

6/26/2017

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it has commenced an underwritten public offering of $100,000,000 in shares of its common sto...

 Continue Reading
6/23/2017
7:00 AM ET
Press Release

Repligen Corporation and Spectrum, Inc. to Join Forces

6/23/2017

- Adds to Repligen a leader in bioprocess filtration with expertise in hollow fiber technology- Strengthens flagship XCell™ ATF product line with an extensive filtration consumables portfolio- Diversi...

 Continue Reading
5/31/2017
7:30 AM ET
Press Release

Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference

5/31/2017

WALTHAM, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will pres...

 Continue Reading
5/24/2017
7:30 AM ET
Press Release

Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference

5/24/2017

WALTHAM, Mass., May 24, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will part...

 Continue Reading
5/9/2017
1:25 PM ET
Press Release

Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference

5/9/2017

WALTHAM, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will pres...

 Continue Reading
Displaying 1 to 5 (of 197 releases)